Back to News
Market Impact: 0.6

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

XLEAPAHALFANGTPLOKEPSXXOMCOPCVXURNMNLRJBLAAPLXLKMSFTIBMPLTRAESVSTNEEPCGEIXSRESRPTIBBXBIXHBHOVBZHDHITMHCTOLLENBGADM
Energy Markets & PricesCommodities & Raw MaterialsTechnology & InnovationCorporate EarningsCompany FundamentalsHealthcare & BiotechNatural Disasters & WeatherMarket Technicals & Flows
Tuesday’s big stock stories: What’s likely to move the market in the next trading session

Monday's market activity saw West Texas Intermediate crude futures up 14% in the past month, while uranium stocks surged, with the Sprott Uranium Miners ETF (URNM) up 15% in June amid growing support for uranium as a reliable energy source. Conversely, utilities underperformed due to an expected heat wave, and Sarepta Therapeutics plummeted 42% after halting a muscular dystrophy drug trial, though some analysts suggest the dip presents a buying opportunity; Bunge saw a 6% increase following China's approval of its merger with Viterra.

Analysis

The market exhibited distinct sector-specific trends. West Texas Intermediate crude futures increased approximately 14% in the past month, contributing to a 2.7% rise in the Energy Select Sector SPDR Fund (XLE) and notable gains in stocks such as APA Corporation (up 16.5%), while Texas Pacific Land Corporation saw a significant 23.6% decline. Uranium equities experienced a robust rally, with the Sprott Uranium Miners ETF (URNM) climbing 15% in June, supported by positive CEO commentary on uranium's reliability and zero-emission benefits for energy grids and data centers. The Technology Select Sector SPDR Fund (XLK) achieved a new high, mirrored by new peaks for Microsoft, IBM, Palantir, and Apple supplier Jabil, which is up 33% over the past three months and reports earnings Tuesday. In contrast, the utilities sector was the S&P's weakest performer on Monday, down 0.5%, despite an impending heatwave that typically increases power demand. The biotech sector faced a substantial setback as Sarepta Therapeutics (SRPT) plummeted 42% following the discontinuation of a drug trial, although one Mizuho analyst suggested this could represent a contrarian buying opportunity. The homebuilder sector, evidenced by the SPDR S&P Homebuilders ETF (XHB) declining 5.5% in the last month, awaits upcoming sentiment data, with many constituent stocks trading well below their highs. Lastly, agricultural commodities and related companies surged; Bunge (BG) appreciated over 15% in one week after China approved its merger with Viterra, and Archer Daniels Midland (ADM) recorded its strongest five-day performance since March 2020, coinciding with a 9% jump in soybean futures to their highest level since autumn 2023.